These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20378049)

  • 1. Influence of Escherichia coli shiga toxin on the mammalian central nervous system.
    Obata F
    Adv Appl Microbiol; 2010; 71():1-19. PubMed ID: 20378049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga toxin-producing Escherichia coli infection.
    Thorpe CM
    Clin Infect Dis; 2004 May; 38(9):1298-303. PubMed ID: 15127344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of typical (enteropathic) hemolytic uremic syndrome.
    Bitzan M; Schaefer F; Reymond D
    Semin Thromb Hemost; 2010 Sep; 36(6):594-610. PubMed ID: 20865636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli Shiga toxin.
    Nakao H; Takeda T
    J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
    Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
    Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
    Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
    Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.
    Serna A; Boedeker EC
    Curr Opin Gastroenterol; 2008 Jan; 24(1):38-47. PubMed ID: 18043231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
    Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
    Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
    Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
    Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin-producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan.
    Mohsin M; Haque A; Ali A; Sarwar Y; Bashir S; Tariq A; Afzal A; Iftikhar T; Saeed MA
    Foodborne Pathog Dis; 2010 Jan; 7(1):85-90. PubMed ID: 19785532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome.
    Petruzziello-Pellegrini TN; Moslemi-Naeini M; Marsden PA
    Virulence; 2013 Aug; 4(6):556-63. PubMed ID: 23955166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS.
    Ge S; Hertel B; Emden SH; Beneke J; Menne J; Haller H; von Vietinghoff S
    Nephrol Dial Transplant; 2012 Jul; 27(7):2768-75. PubMed ID: 22234918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
    Brooks JT; Sowers EG; Wells JG; Greene KD; Griffin PM; Hoekstra RM; Strockbine NA
    J Infect Dis; 2005 Oct; 192(8):1422-9. PubMed ID: 16170761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga toxin-producing Escherichia coli and atypical enteropathogenic Escherichia coli strains isolated from healthy sheep of different populations in São Paulo, Brazil.
    Vettorato MP; de Castro AF; Cergole-Novella MC; Camargo FL; Irino K; Guth BE
    Lett Appl Microbiol; 2009 Jul; 49(1):53-9. PubMed ID: 19413771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of eae and stx genes of atypical enteropathogenic Escherichia coli and non-O157 Shiga toxin-producing Escherichia coli from calves.
    Wani SA; Hussain I; Nabi A; Fayaz I; Nishikawa Y
    Lett Appl Microbiol; 2007 Dec; 45(6):610-5. PubMed ID: 17916128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.